2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$54.29+$0.21 (+0.39%)
Price as of Aug 21, 2026 7:44 PM EDT- $13.4BMarket Cap
- 39.99%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$54.29+$0.21 (+0.39%)
EXEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $54.08 | ||
Change | +$0.39 (+0.73%) | ||
Open | $53.74 | ||
High | $54.68 | ||
Low | $53.70 | ||
Previous Close | $53.69 | ||
Volume | 1,949,764 | ||
30-Day Average Volume | 2,617,275 | ||
1-Week Change | 5.54% | ||
1-Month Change | -3.64% | ||
1-Year Change | 39.99% | ||
3-Year Change | 153.07% | ||
5-Year Change | 193.28% | ||
Fundamentals | |||
Shares Outstanding | 247.8M | ||
Total Assets | $2.5B | ||
Market Cap | $13.4B | ||
Enterprise Value | $13.1B | ||
Period: QTR TTM FY | |||
Revenue | $573.0M | ||
Net Income | $212.1M | ||
Free Cash Flow | $300.9M | ||
EBIT | $262.7M | ||
EBITDA | $269.7M | ||
Net Working Capital | $888.9M | ||
EPS | $0.82 | ||
Enterprise Value/EBITDA | 49 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 7 | ||
P/E | 66 | ||
PEG | 17 | ||
Price/Free Cash Flow | 45 | ||
Price/Operating Cash Flow | 44 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue